RELAPSA in English translation

• relapse
• recurrence
• relapses
• relapsed

Examples of using Relapsa in Croatian and their translations into English

istodobno liječenje relapsa s kratkotrajnom intravenskom primjenom kortikosteroida nije bilo povezano s klinički relevantnim porastom infekcije.
the concomitant treatment of relapses with a short course of intravenous corticosteroids was not associated with a clinically relevant increase of infection.

Olanzapin je indiciran za prevenciju relapsa u bolesnika s bipolarnim poremećajem čije su manične epizode reagirale na liječenje olanzapinom vidjeti dio 5.1.
In patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder see section 5.1.

U bolesnika u kojih postoji visok rizik relapsa, može se razmotriti postupno smanjivanje doze vidjeti dio 4.4.
In patients with a high risk of relapse, dose tapering may be considered see section 4.4.

istovremeno liječenje relapsa kratkom terapijom kortikosteroidima i TYSABRIJEM nije bilo povezano s povećanom stopom infekcija.
concomitant treatment of relapses with a short course of corticosteroids was not associated with an increased rate of infection.

U prvim dvama ispitivanjima, broj relapsa godišnje u bolesnika liječenih lijekom Gilenya bio je upola manji od broja relapsa zabilježenih u bolesnika koji su primali placebo.
In the first two studies, the number of relapses per year among patients treated with Gilenya was around half the number seen in patients given placebo.

U trećem ispitivanju, broj relapsa u bolesnika koji su primali lijek Gilenya bio je također upola manji od broja relapsa zabilježenih u bolesnika koji su primali interferon beta.
In the third study, the number of relapses in patients receiving Gilenya was also around half the number seen in patients given beta-interferon.

NS5A RAV-ovi su u vrijeme relapsa bili opaženi u 11/13 pacijenata za genotip 1a: samo Q30R.
NS5A RAVs were seen at the time of relapse in 11/13 patients for genotype 1a: Q30R alone[n 2], Y93C[n 1], Y93H/C.

Dokazano je da Plegridy smanjuje broj relapsa u bolesnika oboljelih od relapsno-remitirajućeg oblika MS-a u glavnom ispitivanju koje je trajalo dvije godine i obuhvatilo je 1.516 bolesnika.
Plegridy has been shown to reduce the rate of relapses in patients with relapsing-remitting MS in a main study which lasted two years and involved 1,516 patients.

Simptomi mogu u potpunosti nestati nakon završetka relapsa, no s vremenom se neke tegobe mogu zadržati i između relapsa..
Symptoms may disappear completely after the relapse is over, but over time, some problems may remain between relapses..

Simptomi relapsa mogu potpuno nestati kada relaps završi,
Symptoms of a relapse may disappear completely when the relapse is over,

Dokazano je da je lijek Tecfidera djelotvoran u smanjivanju broja relapsa u bolesnika oboljelih od relapsno-remitirajući MS-a,
Tecfidera has been shown to be effective in reducing the number of relapses in patients with relapsing- remitting MS

Dokazano je da lijek Tecfidera smanjuje broj relapsa u bolesnika oboljelih od relapsno-remitirajućeg MS-a,
Tecfidera has been shown to reduce the number of relapses in patients with relapsing-remitting MS

Incidencija relapsa tijekom 6-mjesečnog razdoblja dvostruko slijepog praćenja iznosila je 14% u bolesnika koji su uzimali lijek Duloksetin Lilly i 42% u onih koji su uzimali placebo.
The incidence of relapse during the 6-months double-blind follow-up period was 14% for Duloxetine Lilly and 42% for placebo.

Kaplan-Meierova procjena vjerojatnosti relapsa u 28. tjednu bila je 42,2% za lurasidon
The Kaplan-Meier estimates of the probability of relapse at Week 28 were 42.2% for lurasidone

Sigurnost i djelotvornost intravenskog temsirolimusa za liječenje relapsa i/ili refraktornog limfoma plaštenih stanica ispitane su u sljedećem kliničkom ispitivanju faze III.
The safety and efficacy of intravenous temsirolimus for the treatment of relapsed and/or refractory mantle cell lymphoma were studied in the following Phase 3 clinical study.

Dva ispitivanja s 2257 bolesnika uspoređivala su učinke lijeka Aubagio s placebom na smanjenje broja relapsa po bolesniku u godini dana nazvano"godišnja stopa relapsa..
Two studies involving 2,257 patients compared the effects of Aubagio with placebo in reducing the number of relapses per patient per year called the‘annualised relapse rate.

Kao monoterapija, lijek Tysabri bio je učinkovitiji u smanjenju broja relapsa od placeba.
Tysabri used on its own was more effective than placebo in reducing the number of relapses.

praška 1 jednom dnevno za prevenciju relapsa.
powder 1 once a day for the prevention of relapse.

Neke su studije pokazale da će dojenje barem prva dva mjeseca spriječiti razvoj relapsa, druge studije nisu pokazale takvo blagotvorno djelovanje dojenja.
Some studies have shown that breast-feeding for at least the first two months to prevent the development of relapse, Other studies have not shown such a beneficial effect of breastfeeding.

obilježen je smjenjivanjem relapsa i remisija.
marked by a removal of relapse and remission.